Vaccine overview:

• For active immunisation of clinically healthy pigs from 17 days of age from farms affected with PRRSV type I.
• One 1 ml dose administered via a single intramuscular injection
• Onset of immunity at 3 weeks with a duration of 26 weeks

The only piglet-specific PRRS vaccine designed to maximise pig performance in all stages of production:

• Reduction of respiratory clinical signs
• Reduces viraemia in pigs exposed to the virus
• Reduction of lung lesions and virus load in lung tissues.
• Reduces the negative effects of infection on daily weight gain​​
• Also efficacious among piglets with high levels of maternal antibodies
• The only vaccine approved to reduce respiratory clinical signs caused by PRRS
• Protection that lasts until slaughter. Healthier, heavier piglets with greater weight gains at all stages of production

For more information click here: